Back to trial detailsIntake questionnaire
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Applying to Ohio State University Comprehensive Cancer Center · Columbus, Ohio
Answer a few short questions to share with the research team.
0 of 4 answered